These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 15050424
1. Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats. Yoshitake T, Kehr J. Life Sci; 2004 Apr 23; 74(23):2865-75. PubMed ID: 15050424 [Abstract] [Full Text] [Related]
2. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo. Yoshitake T, Yoshitake S, Yamaguchi M, Ogren SO, Kehr J. Neuropharmacology; 2003 Feb 23; 44(2):206-13. PubMed ID: 12623219 [Abstract] [Full Text] [Related]
5. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses. Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM. Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846 [Abstract] [Full Text] [Related]
6. The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia. Kline AE, Massucci JL, Dixon CE, Zafonte RD, Bolinger BD. J Neurotrauma; 2004 Feb 17; 21(2):175-85. PubMed ID: 15000758 [Abstract] [Full Text] [Related]
7. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG, Bonaventure P. Eur J Pharmacol; 2004 Mar 08; 487(1-3):125-32. PubMed ID: 15033384 [Abstract] [Full Text] [Related]
8. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat. Yu H, Liu Y, Hacksell U, Lewander T. J Pharm Pharmacol; 1996 Jan 08; 48(1):41-5. PubMed ID: 8722493 [Abstract] [Full Text] [Related]
9. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Invernizzi R, Bramante M, Samanin R. Brain Res; 1995 Oct 23; 696(1-2):62-6. PubMed ID: 8574685 [Abstract] [Full Text] [Related]
10. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis. Nakai K, Fujii T, Fujimoto K, Suzuki T, Kawashima K. Neurosci Res; 1998 May 23; 31(1):23-9. PubMed ID: 9704975 [Abstract] [Full Text] [Related]
11. Counteraction of the rapid tolerance to 8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia in rats by activation of the GABAA receptor-chloride channel complex. Kelder D, Ross SB. Pharmacol Toxicol; 2002 Jan 23; 90(1):14-9. PubMed ID: 12005107 [Abstract] [Full Text] [Related]
12. Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. Assié MB, Koek W. Br J Pharmacol; 1996 Nov 23; 119(5):845-50. PubMed ID: 8922730 [Abstract] [Full Text] [Related]
13. A brain microdialysis study on 5-HT release in freely moving rat lines selectively bred for differential 5-HT1A receptor function. Gonzalez LE, Parada MA, Tucci S, Teneud L, Overstreet DH, Hernandez L. Braz J Med Biol Res; 2003 Feb 23; 36(2):263-7. PubMed ID: 12563529 [Abstract] [Full Text] [Related]
14. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors. Orús L, Pérez-Silanes S, Oficialdegui AM, Martínez-Esparza J, Del Castillo JC, Mourelle M, Langer T, Guccione S, Donzella G, Krovat EM, Poptodorov K, Lasheras B, Ballaz S, Hervías I, Tordera R, Del Río J, Monge A. J Med Chem; 2002 Sep 12; 45(19):4128-39. PubMed ID: 12213056 [Abstract] [Full Text] [Related]
15. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment. Kantor S, Graf M, Anheuer ZE, Bagdy G. Eur Neuropsychopharmacol; 2001 Feb 12; 11(1):15-24. PubMed ID: 11226808 [Abstract] [Full Text] [Related]
16. Enantioselective high-performance liquid chromatographic analysis of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin. Application to a pharmacokinetic-pharmacodynamic study in rats. Zuideveld KP, Treijtel N, Van der Graaf PH, Danhof M. J Chromatogr B Biomed Sci Appl; 2000 Jan 28; 738(1):67-73. PubMed ID: 10778927 [Abstract] [Full Text] [Related]
17. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone. Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA. Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724 [Abstract] [Full Text] [Related]
18. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia. Zuideveld KP, Treijtel N, Maas HJ, Gubbens-Stibbe JM, Peletier LA, van Der Graaf PH, Danhof M. J Pharmacol Exp Ther; 2002 Jan 07; 300(1):330-8. PubMed ID: 11752133 [Abstract] [Full Text] [Related]
19. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan. Jacobsen JP, Nielsen EØ, Hummel R, Redrobe JP, Mirza N, Weikop P. Psychopharmacology (Berl); 2008 Aug 07; 199(2):137-50. PubMed ID: 18496675 [Abstract] [Full Text] [Related]
20. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. Meller E, Li H, Carr KD, Hiller JM. J Pharmacol Exp Ther; 2000 Feb 07; 292(2):684-91. PubMed ID: 10640306 [Abstract] [Full Text] [Related] Page: [Next] [New Search]